Jacqueline Adam

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence

Thomas Gentinetta, John D. Belcher, Valérie Brügger‐Verdon et al. · Journal of Clinical Medicine · 2022 · 37 citations · Full text

Medicine, Hematology, Pharmacology +16

Disease progression of alpha-mannosidosis and impact on patients and carers – A UK natural history survey

Jacqueline Adam, Rachel Malone, Jennifer Lee et al. · Molecular Genetics and Metabolism Reports · 2019 · 31 citations · Full text

Life Sciences, Hematology, Internal Medicine +15

The Mechanism of Inhibition of Factor III (Thromboplastin) Activity by Apolipoprotein B-100

Camille Ettelaie, Nicola James, Barry Wilbourn et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1996 · 21 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Comparison of the Inhibitory Effects of ApoB100 and Tissue Factor Pathway Inhibitor on Tissue Factor and the Influence of Lipoprotein Oxidation

Camille Ettelaie, Barry Wilbourn, Jacqueline Adam et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 17 citations

Life Sciences, Biochemistry, Molecular Biology +10

The role of the C‐terminal domain in the inhibitory functions of tissue factor pathway inhibitor

Camille Ettelaie, Jacqueline Adam, Nicola James et al. · FEBS Letters · 1999 · 16 citations

Medicine, Biochemistry, Molecular Biology +17